Alpine Immune Sciences Inc reports results for the quarter ended in September - Earnings Summary

Alpine Immune Sciences

11/11/2021 03:40

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 55 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for earnings of one cents per share.
* Revenue rose 345.2% to $8.52 million from a year ago; 
analysts expected $21.19 million. 
* Alpine Immune Sciences Inc's reported EPS for the quarter was
a loss of 55 cents​.
* The mean earnings estimate of analysts had risen by
about 102.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Alpine Immune Sciences Inc shares had risen by 21.3% this
quarter and gained 2.7% so far this year.
* The company reported a quarterly loss of $13.49 million.
* Wall Street's median 12-month price target for Alpine Immune
Sciences Inc is $21.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 03:40 a.m.
 ​All figures in US dollars unless otherwise stated